David Rosmarin, MD

David Rosmarin, MD, discussed STAT6 inhibitors, ITK inhibitors, bispecifics, hand eczema, and endpoints at the RAD 2026 Conference.

Rosmarin discussed new late-breaking data from ADVANCE-AA at AAD 2026.

David Rosmarin, MD, discusses results from ADORING 3 presented at AAD 2025.

Dr. Woolery-Lloyd shares her advice for vitiligo providers and tips for helpful communication with patients.

Drs. Pandya, Rosmarin and King share their enthusiasm about emerging therapies and data that is available for ruxolitinib.

Vitiligo clinical experts discuss the role of maintenance therapy in preventing recurrence of vitiligo.

Drs. Woolery-Lloyd, King and Pandya discuss time to re-pigmentation of different areas in vitiligo.

Drs. Woolery-Lloyd, Rosmarin and Pandya discuss various treatment options for vitiligo and when and where they might use them.

Dr. Rosmarin and other panelists share their thoughts on how to treat different areas of the body and the role of tattoos.

Dr. Pandya shares his conversations with patients about re-pigmentation of segmental and non-segmental vitiligo and treatment options that exist.

Drs. Pandya and King discuss challenges in re-pigmentation, including glabrous skin and areas that may not re-pigment.

Dr. Rosmarin provides an overview of models of re-pigmentation in vitiligo.

Drs. Rosmarin and King discuss the importance of shared-decision making and understanding of patient goals in managing vitiligo.

Drs. Pandya and King discuss patient’s visit and how providers can help set expectations about the disease course.

Dr. Woolery-Lloyd shares her approach to talking to patients about vitiligo.

Drs Woolery-Lloyd, King and Pandya share how vitiligo affects patients’ quality of life.

Drs Rosmarin, King, and Pandya give an overview of clinical presentation and classification of vitiligo.

Drs Pandya discusses vitiligo pathophysiology, the role of genetic and environmental factors, and how to communicate with patients about it.

A vitiligo expert, Dr Amit Pandya, provides an overview of vitiligo.